Real-World Data Integration in U.S. Clinical Submissions
Real-World Data Integration in U.S. Clinical Submissions Integrating Real-World Data into U.S. Clinical Trial Submissions: Regulatory and Operational Insights Introduction The use of real-world data (RWD) in U.S. clinical trial submissions has expanded dramatically following the 21st Century Cures Act of 2016, which directed the Food and Drug Administration (FDA) to evaluate how real-world evidence…
Read More “Real-World Data Integration in U.S. Clinical Submissions” »
